Literature DB >> 20865664

Immunohistochemical localization of galectins-1 and -3 and monitoring of tissue galectin-binding sites during tubular regeneration after renal ischemia reperfusion in the rat.

David Vansthertem1, Stéphanie Cludts, Denis Nonclercq, Annabel Gossiaux, Sven Saussez, Alexandre Legrand, Hans-Joachim Gabius, Gérard Toubeau.   

Abstract

Endogenous lectins act as effectors of cellular activities such as growth regulation, migration and adhesion. In this study, we report the histochemical detection of galectins and their binding sites in rat kidneys after ischemic injury (35 min) with regard to renal regeneration. In this context, we have shown in a previous publication (Vansthertem et al., 2008) that extrarenal cells (CD44+, vimentin +) could be involved in this process of tubular restoration. In controls, galectin-1 is expressed by fusiform-shaped cells within cortical and medullar interstitium. Two days after ischemia, the number of positive interstitial cells increased temporarily within OSOM in the vicinity of altered tubules to later reach control level. After ischemia, we identified a population of galectin-3 (+), CD44 (+), and vimentin (+) interstitial round cells located in the outer stripe of outer medulla (OSOM) in the vicinity of necrotic tubules, but also in the lumen of adjacent blood vessels. The immunocytochemical characteristics of theses cells, along with their distribution within OSOM, suggest the involvement of a unique cell population during kidney regeneration. On the other hand, the distribution and density of binding sites for galectins within OSOM were not modified after ischemia and remained similar to controls. Altogether, our observations suggest that galectin-3 may be involved in the complex process of kidney regeneration following ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865664     DOI: 10.14670/HH-25.1417

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

1.  Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.

Authors:  Umadevi V Wesley; Raghu Vemuganti; Emine R Ayvaci; Robert J Dempsey
Journal:  Brain Res       Date:  2012-12-14       Impact factor: 3.252

2.  Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.

Authors:  Kathryn C B Tan; Ching-Lung Cheung; Alan C H Lee; Joanne K Y Lam; Ying Wong; Sammy W M Shiu
Journal:  Diabetologia       Date:  2018-02-07       Impact factor: 10.122

3.  Galectin fingerprinting in naso-sinusal diseases.

Authors:  Anaëlle Duray; Thibault De Maesschalck; Christine Decaestecker; Myriam Remmelink; Gilbert Chantrain; Jennifer Neiveyans; Mihaela Horoi; Xavier Leroy; Hans-Joachim Gabius; Sven Saussez
Journal:  Oncol Rep       Date:  2014-05-23       Impact factor: 3.906

Review 4.  The Role of Galectin-3 in the Kidneys.

Authors:  Szu-Chia Chen; Po-Lin Kuo
Journal:  Int J Mol Sci       Date:  2016-04-14       Impact factor: 5.923

5.  Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.

Authors:  Deepa M Gopal; Maya Kommineni; Nir Ayalon; Christian Koelbl; Rivka Ayalon; Andreia Biolo; Laura M Dember; Jill Downing; Deborah A Siwik; Chang-Seng Liang; Wilson S Colucci
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

6.  Galectin-1 in early acute myocardial infarction.

Authors:  Suhail Al-Salam; Satwat Hashmi
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

7.  Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury.

Authors:  Carla P Carlos; Analice A Silva; Cristiane D Gil; Sonia M Oliani
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

Review 8.  Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target.

Authors:  Louis Boutin; François Dépret; Etienne Gayat; Matthieu Legrand; Christos E Chadjichristos
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.